Recent EVAX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2025 01:30:24 PM
- Evaxion receives grant funding to design new polio vaccine • GlobeNewswire Inc. • 06/03/2025 01:15:31 PM
- Evaxion announces business update and first quarter 2025 financial results • GlobeNewswire Inc. • 05/27/2025 11:30:48 AM
- Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025 • GlobeNewswire Inc. • 05/23/2025 12:00:51 PM
- Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01 • GlobeNewswire Inc. • 05/22/2025 12:00:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/05/2025 12:45:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2025 12:30:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2025 12:16:21 PM
- 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting • GlobeNewswire Inc. • 04/28/2025 12:00:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/10/2025 12:15:36 PM
- Evaxion to present at World Vaccine Congress • GlobeNewswire Inc. • 04/10/2025 12:00:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/07/2025 10:00:16 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/01/2025 01:33:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/01/2025 11:45:17 AM
- Evaxion announces business update and full year 2024 financial results • GlobeNewswire Inc. • 04/01/2025 11:30:35 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2025 12:15:31 PM
- Evaxion to announce business update and full year 2024 financial results on April 1, 2025 • GlobeNewswire Inc. • 03/27/2025 12:00:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/26/2025 08:30:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/26/2025 08:01:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2025 08:45:33 PM
- Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting • GlobeNewswire Inc. • 03/25/2025 08:30:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/25/2025 04:15:12 AM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 03/13/2025 08:01:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2025 01:15:19 PM
- Evaxion to present at numerous upcoming conferences • GlobeNewswire Inc. • 03/04/2025 01:00:00 PM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM